APYX vs RL · rev $48.1M vs P/E 24, rev $8.11B
Apyx Medical Inc (APYX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
APYX currently screens at market cap $179.6M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the APYX and RL stock pages for the full models.
Not investment advice.